Evoke Pharma Inc (EVOK)

NASDAQ
1.1100
-0.0300(-2.63%)
  • Volume:
    92,413
  • Bid/Ask:
    1.1100/1.1200
  • Day's Range:
    1.0800 - 1.1600

EVOK Overview

Prev. Close
1.14
Day's Range
1.08-1.16
Revenue
110K
Open
1.16
52 wk Range
1.06-6.05
EPS
-0.53
Volume
92,413
Market Cap
35.93M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
277,055
P/E Ratio
-
Beta
1.21
1-Year Change
-67.71%
Shares Outstanding
32,371,954
Next Earnings Date
11 Aug 2021
What is your sentiment on Evoke Pharma Inc?
or
Vote to see community's results!

Evoke Pharma Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellSellStrong Sell
Technical IndicatorsBuyBuyStrong SellStrong SellStrong Sell
SummaryBuyBuyStrong SellStrong SellStrong Sell

Evoke Pharma Inc Company Profile

Evoke Pharma Inc Company Profile

Employees
5

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.